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Nomenclatureily of cationic, α-helical, antimicrobial peptides that were isolated from a Korean
frog, Glandirana emeljanovi (formerly classiﬁed as Rana rugosa) and represent one of the structurally well-
characterized groups. Among six gaegurins, gaegurin 4 (renamed herein esculentin-2EM), gaegurin 5
(brevinin-1EMa), and gaegurin 6 (brevinin-1EMb) have been investigated comprehensively in terms of
structure–activity relationships. In this paper, we ﬁrst suggest renaming of gaegurins according to a recently
raised rule of systematic nomenclature. Then, the current understanding of gaegurins is reviewed by
summarizing their structure–activity relationships. In particular competing arguments on gaegurins are
synthetically inspected. Finally their action mechanism and structural requirements will be discussed.
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The anuran skin has served as an exceedingly rich source of
antimicrobial peptides [1–3]. Several hundreds of antimicrobialnmr.snu.ac.kr (B.-J. Lee).
08 Published by Elsevier B.V. All ripeptides with approximately 10–50 amino acids have been isolated
from various species of frogs and many of them have been considered
as a potential source of therapeutic agents [1–6]. Gaegurins (GGNs)
are one of the early isolated groups of frog-skin antimicrobial peptides
that manifest a broad spectrum of antimicrobial activity against
Gram-positive and Gram-negative bacteria, fungi, and protozoa, with
little hemolytic activity [7–10]. Anticancer activities have been alsoghts reserved.
1621H.-S. Won et al. / Biochimica et Biophysica Acta 1788 (2009) 1620–1629reported for GGN5, GGN6, and their derivatives [9,10]. Accordingly,
GGN4, GGN5, and GGN6 among six GGNs have been structurally well-
characterized to be investigated in terms of therapeutic development.
Prior to the review on their structural aspects, we ﬁrst clarify the frog
species and the peptide names, in agreement with the recent
suggestion of systematic terminology, since the taxonomy of gaegur-
ins was proposed to be revised in accordance with a new classiﬁcation
of frog species and a systematic rule of nomenclature [11].
1.1. Isolation and identiﬁcation of gaegurins
Gaegurins, a group of six membrane-active antimicrobial peptides,
were ﬁrst isolated in 1994 from the skin homogenate and extradermal
secretion of a Korean frog, Rana rugosa [7]. Subsequently in 1995, two
complete cDNAs encoding GGN4 and GGN5 including their precursor
polypeptides were isolated from a library constructed with the frog
skin mRNAs [12]. It was also conﬁrmed that gaegurins are extensively
expressed in the skin tissue, but not in liver and muscle. Finally, the
gene organization of GGN4 and its regulation of expression were
elucidated in 2000 [13]. Despite this clear identiﬁcation, gaegurins
from the species R. rugosa in Korea have provided a questionable
example, since a different group of antimicrobial peptides were
isolated from the same species of frog. Independent study by different
laboratory on the skin extracts of the same species R. rugosa inhabiting
in Japan resulted in isolation of three peptides named rugosins, which
were different from gaegurins [14]. Although a high sequence
similarity can be observed between rugosins and gaegurins (Fig. 1;
GGN2 for rugosin A, GGN1 for rugosin B, and GGN4 for rugosin C), the
appreciable differences could not be expected from exactly the same
species. Similar examples, where different peptide groups were
isolated from nominally the same species of frog in different
geographical areas, are available from Hylarana güntheri and Rana
esculenta [11,15,16]. These confusing results alternatively suggest that
taxonomic classiﬁcation of frog species should be revised to reﬂect the
considerable polymorphism. Fortunately, the discrepancy between
gaegurins and rugosins is now resolved by recent advances in
phylogenetic analysis of the family Ranidae (the order Anura; the
class Amphibia). As Ranidae was one of the most diverse amphibian
groups, the taxonomy of ranid species especially in the subfamily
Raniae has been controversial and revised many times [17]. In
particular, the genus Rana, which has been considered as the most
diverse and worldwide group of anurans with approximately 250
species [18,19], is currently distributed to 16 different genera in Ra-
nidae [20]. As noted by Conlon [11], according to the well-establishedFig. 1. Comparison of primary structures of gaegurins and their related peptides. New nam
introduced tomaximize the sequence identities, which at aligned positions are indicated by t
and gaegurin 5′ are represented only at the positions with different amino acids from the vtaxonomy in the ASW database [20], the former species R. rugosa in
Korea and Japan are reclassiﬁed as Glandirana emeljanovi and Glan-
dirana rugosa, respectively. Thus, gaegurins and rugosins should be
regarded as independent groups of antimicrobial peptides isolated
from similar but different species of frogs.
1.2. Nomenclature of gaegurins
Molecular diversity of frog-skin antimicrobial peptides is often
useful as taxonomic and phylogenetic markers to clarify evolutionary
aspects [15,19,21,22]. Investigators of frog-skin antimicrobial peptides
have named the newly identiﬁed peptides mainly referring to the
name of frog species. However, this terminology was not valuable to
reﬂect the evolutionary relationships. Despite the enormous reports of
several hundreds of frog-skin antimicrobial peptides from ranid
species, an established rule of nomenclature has not been shared
and some names were arbitrary. As suggested recently by Conlon [11],
the system of nomenclature used by Simmaco et al. [23,24] would be
the best choice. In this naming, orthologs of an originally discovered
parent peptide are characterized by the initial letter(s) of species, set
in upper case, with paralogs being assigned letters set in lower case.
Current 14 representatives for the parent peptides to designate
peptide families were summarized by Conlon [11].
Gaegurins were the ﬁrst isolation of frog-skin antimicrobial
peptides in Korea and the authors named them referring to a Korean
word, Gaegury, which means frog [7]. As shown in Fig. 1, the size and
amino acid sequence of gaegurins exhibits a similarity to that of
brevinins (brevinin-1 for GGNs 5 and 6 and brevinin-2 for GGNs 1 to
3) and esculentin-2 (for GGN4), which had been isolated earlier from
the Japanese frog Pelophylax porosus (formerly classiﬁed as Rana
brevipoda porsa) [26] and the European frog Pelophylax lessonae/
ridibundus (formerly R. esculenta) [25], respectively. Therefore,
according to the Conlon's scheme of taxonomy, the names of gaegurins
are revisable as follows. GGN1 and GGN2, belonging to the brevinin-2
family, are revised to brevinin-2EMa and brevinin-2EMb, respectively,
where the EM is derived from the frog species name (EMeljanovi). We
suggest a new name brevinin-2EMb′ (or GGN2′) for GGN3, of which
the sequence is almost the same as that of GGN2 (brevinin-2EMb)
with only a single substitution at position 12. GGN4 has been roughly
classiﬁed by Conlon [11] as a member of brevinin-2 family, together
with GGNs 1–3. However, the longer peptide GGN4 is distinguished
from GGNs 1 to 3 in the brevinin-2 family and shows a sequence
similarity to esculentin-2 with the same number of amino acid
residues (Fig. 1). Thus, GGN4 is assignable to the esculentin-2 family,e of each peptide, suggested in this paper, is presented in parenthesis. Gaps (—) were
he same colors. For clarity, the sequences of rugosin B, gaegurin 3, gaegurin 4′, rugosin C,
ery upper line sequences.
1622 H.-S. Won et al. / Biochimica et Biophysica Acta 1788 (2009) 1620–1629rather than to the brevinin-2 family, and can be replaced by
esculentin-2EM. Finally, GGN5 and GGN6 in the brevinin-1 family
can be renamed as brevinin-1EMa and brevinin-1EMb, respectively.
Similarly, rugosins from Glendirana rugosa are revisable as brevinin-
2Ra, brevinin-2Rb, and esculentin-2R, as indicated in Fig. 1.
In addition to gaegurins, some other peptide names from Korean
fogs are now revisable. The peptides named esculentin-1c and
brevinin-1Ed from the Korean R. esculenta [16] can be renamed as
esculentin-1N and brevinin-1N, respectively, since the frog species is
now assignable to Pelophylax nigromaculatus according to the newly
updated taxonomy in the ASW database [20]. A brevinin-2 family
peptide, nigrosin-1 from the Korean Rana nigromaculata [26], which
can be now reclassiﬁed as Pelophylax chosenica, is desirable to be
renamed as brevinin-2CH. Then, the peptide nigrosin-2 from the same
species can be called just nigrosin. Since nigrosin has a unique primary
structure, it should be used as a representative term to designate an
independent peptide family, as also supported by Conlon [11].
1.3. Amino acid sequences of gaegurins
Amino acid sequences of the six gaegurins were originally revealed
by peptide sequencing [7]. Among them, GGN4 and GGN5 were
additionally supported by cDNA isolations [12]. However, the peptide
sequence derived from cDNA indicated Lys 35 in GGN4 and Phe 17 in
GGN5 instead of the formerly reported Leu and Lys, respectively. Then,
the authors corrected the original sequences of GGN4 and GGN5,
through an erratum report [Erratum of 7]. The structural research on
GGN4 [27] has been performed on the latter sequence, since it was
initiated using the cDNA clones. In contrast, the structure of GGN5was
investigated with a synthetic peptide of the former sequence [28],
without recognition of the erratum report. However, since the
relevant activities were checked, the determined structure would be
still valid to interpret structure–activity relationships of GGN5.
Moreover, it is not reasonable to conclude depending on the isolated
cDNA that the original sequence was misread. In the case of brevinins
and esculentins from the former R. esculenta, the peptide sequences
deduced by cDNA cloning also showed slight differences from those
reported originally from the skin secretion [23,24]. This result
promoted more detailed examination of the skin secretion, and ﬁnally
it was revealed that several variants with one or a few amino acid
substitutions exist in a single family. GGNs also support this notion
since GGN3 showed a single variation from GGN2 (Fig. 1). Thus, we
suggest that all the GGN sequences shown in Fig. 1 are relevant to
naturally occurring peptides. Exceptionally, we ﬁnd that the GGN6
sequence has been mis-introduced in some literatures [4,26,28,29] by
showing Phe instead of Lys 19. To revise the peptide names as in Fig. 1,
we assigned GGN4 to the cDNA-derived sequence and GGN5 to the
original sequence, since those sequences were employed for struc-
ture-functional investigations [9,27–32]. Then the other synonymous
sequences, which have not been used for any other studies, were
designated as GGN4′ (esculentin-2EM′) and GGN5′ (brevinin-1EMa′),
respectively.
2. Structure–activity relationships of gaegurins
Molecular diversity of antimicrobial peptides is so great that it is
very difﬁcult to deﬁnitely categorize them in terms of structure. Just
broadly, antimicrobial peptides are often classiﬁed into 3 structural
classes [5,33,34]: the linear α-helical peptides, the peptides with
several disulﬁde bonds stabilizing β-sheet or α/β structure, and the
peptides with unusual predominance of certain amino acid(s) or
unusual structure. Gaegurins belong to the ﬁrst class, of which
membrane permeation results in membrane disruption via a ‘barrel-
stave’ or ‘toroidal’ pore formation or a ‘carpet-like’ disintegration of
membrane [1,4,35–37]. Restricted to anuran-skin antimicrobial pep-
tides, the following classiﬁcation is also available [1]: linear amphi-pathic α-helical peptides, amphipathic α-helical peptides with a C-
terminal disulﬁde bridge, and the other unique peptides with
relatively shorter length or distinct disulﬁde bond. Gaegurins
represent a group of cationic, amphipathic, α-helical, antimicrobial
peptides with a C-terminal disulﬁde bond. The positive charges
abundant in this group of peptides are important to generate
selectivity, by interacting discriminatively with bacterial membranes
that are heavily populated by lipids with negatively charged
phospholipid headgroups and eukaryotic membranes, of which
surface is principally zwitterionic with no net charge [5,33–40]. The
amphipathic characteristic of the helix is crucial for membrane
interaction and available by positioning hydrophobic amino acids on
one side and hydrophilic residues on the other side from the helical
axis (Fig. 2,Fig. 3,Fig. 4). The helical structure is often induced upon
interactionwith membranes, while the peptides are poorly structured
in aqueous solution [5,38–40]. To induce that functional conformation
relevant to peptide activity, experimental model systems mimicking
membrane environments are often used for structure determination
[37,41]. For example, organic co-solvents such as triﬂuoroethanol
(TFE) provide a hydrophobic environment as the core of membrane,
and detergent micelles such as sodium dodecylsulfate (SDS) and
dodecylphosphocholine (DPC) micelles simply mimic the membrane
structure. As a most advanced model membrane, lipid vesicles with
various compositions are applied. The three-dimensional structures of
gaegurins 4, 5, 6, and their analogues in membrane-mimetic
environments are presently available, solved by NMR groups in
Korea, and provide an insight into their structure–activity
relationships.
2.1. Insight into the Rana box, the C-terminal cyclic heptapeptide with a
conserved disulﬁde bond
All of the six gaegurins possess two strictly conserved cysteines
that form a disulﬁde bond (Fig. 1). The cyclic heptapeptide region by
this disulﬁde bond at the C-terminus is called ‘Rana box’, since it was
frequently observed in majority of ranid antimicrobial peptides.
Among the 15 peptide families from Ranidae (14 families categorized
by Conlon [11] plus herein tigerinins [42]), only temporins are devoid
of the C-terminal cyclization. Some modiﬁcations of the Rana box are
observed in japonicin-2, palustrin-2, ranacyclin, ranatuerin-2, and
tigerinin families, where the C-terminal position and/or the peptide
size of cyclization are different. The Rana box region adopts a helical
loop-like fold stably constrained by the disulﬁde bridge (Fig. 4) [26–
30,43]. Functional importance of this conserved moiety can be simply
inferred from the fact that C-terminal truncations of the peptides
often diminish their antimicrobial activity. For example, an ranalexin
analogue with a single amino acid deletion of the last cysteine and a
GGN4 analogue where the C-terminal nine residues were truncated
had markedly reduced antimicrobial activity [44,45]. GGN6 becomes
insoluble upon truncation of the Rana box [10]. However, the exact
role of the Rana box still remains ambiguous and controversial and it is
arguable whether the conserved disulﬁde bond is always a require-
ment for activity.
2.1.1. Reduction of the disulﬁde bond
Researches on the structural and functional role of the disulﬁde
bridge have employed either a reduced form with free cysteines
[27,28,43,46] or a linear mutant where the cysteines were replaced by
serines or chemically modiﬁed to be unable to form disulﬁde bond
[28,46–51]. The reduced form was conﬁrmed by monitoring the
change of molecular mass, NMR spectra, and/or susceptibility to
carboxypeptidase Y that cleaves polypeptides from the C-terminus
[27]. The reduced GGN4 and GGN5, compared with the native
(oxidized) ones, did not show any signiﬁcant difference in activity
[27,28]. Even the three-dimensional structures in membrane-mimetic
environments were very similar to those of the native (oxidized)
Fig. 2. Amphipathic characteristics of the N-terminal (top panels) and the C-terminal (bottom panels) helix of GGN4 in 50% TFE/water (A, B) and in 80% methanol/water (C),
illustrated as helical wheel diagrams (A, C) and a three-dimensional structure (B). Hydrophobic residues are colored red and hydrophilic residues blue. Glycines are regarded as a
neutral amino acid (A, C) or a hydrophilic amino acid (B). The interface between the hydrophobic and the hydrophilic sides is indicated by dotted arrows (A, C).
1623H.-S. Won et al. / Biochimica et Biophysica Acta 1788 (2009) 1620–1629forms, with their helical length shortened just by one or two residues
at the C-terminus. Despite the loss of disulﬁde bond, the loop-like fold
at the Rana box region was preserved, although it was rather loosely
deﬁned in the reduced forms. Even in the reduced forms, the central
residues of the Rana box showed a slow exchange of the backbone
amide protons, probably due to hydrogen bonds [27,28]. Similar
observations were obtained from the ranalexin (Rnx) and brevinin-
1E, where the reduction of the disulﬁde bond resulted in a just
tolerable decrease of activity [43,46,47]. The helical contents of the
reduced and oxidized brevinin-1E amide, deduced from CD spectra in
TFE and various concentrations of SDS, were comparable to each other
[46,47]. In the three-dimensional structure of the reduced Rnx,
determined in detergent micelles, the helix was just two residues
shorter at the C-terminus, and the C-terminal loop structure was
roughly close to that observed in native (oxidized) Rnx [43]. All these
consistent results of GGN4, GGN5, Rnx and brevinin-1E suggest that
the disulﬁde bond does not play a major role in structure and activity.
Exceptionally, it was noteworthy that the deletion of the C-terminal
cysteine of Rnx remarkably impaired its activity [44]. Thus, at least inFig. 3.Model for membrane permeation of GGN4, suggested in this review. The N-terminal a
hydrophilic and red for hydrophobic face. The ion channels formed by helical bundle of GGN
aggregates in the ion channels are displayed.Rnx, the cysteine residue at the C-terminal end is crucial for activity,
regardless of disulﬁde bond formation.
Similar approach to reduced GGN6 showed a contrary result [48].
The reduced GGN6 amide almost completely lost the antimicrobial
activity while the oxidized form was fully active. Conformational
behaviors were also different between the reduced and oxidized
forms. The oxidized form maintained approximately 70% (estimated
by CD spectroscopy) α-helix contents in the presence of 1.25 to
25 mM SDS. Although the helical content of the reduced form in
25 mM SDS solution was comparable to that of the oxidized form, it
was appreciably decreased at 2.5 mM SDS, which is below the SDS
critical micelle concentration (8.1 mM; [52]). In addition, at lower
concentration (1.25 mM) of SDS, the reduced form was not soluble
and precipitated. Similarly, the truncation of the Rana box in GGN6
made the peptide insoluble in water [10]. Since the majority of
hydrophilic amino acids in GGN6 are located within the Rana box (Fig.
1), the insolubility of the N-terminal fragment lacking the Rana box
could be expected from its strong hydrophobicity with no charged
residues. In contrast, the precipitation of the reduced GGN6 suggestsnd the C-terminal amphipathic helices are represented by cylinders, with blue color for
4 are indicated by up-down arrows. For clarity, only two monomer units of the GGN4
Fig. 4. NMR-derived solution structure of GGN5 in SDS micelles and its membrane-binding model. Backbone structure is displayed as a ribbon model with side chains colored red,
blue, green and yellow for hydrophobic, hydrophilic, proline and cysteine residues, respectively.
1624 H.-S. Won et al. / Biochimica et Biophysica Acta 1788 (2009) 1620–1629that the peptide possess a quite lower propensity to adopt a proper
amphipathic helical structure and/or a higher tendency to form
unfavorable aggregates.
The decreased helical propensity in reduced form has been also
observed from Rnx and brevinin-1E just in water [43,46,47]. Although
poorly structured, small amount of helical propensity in the 12-16
segment could be evidenced by NMR spectroscopy, for the native
(oxidized) Rnx but not for its reduced form [43]. The far-UV CD
spectrum of the native (oxidized) brevinin-1E amide also indicated a
detectable amount of helical content in water, but the spectrum of
reduced form did not [46,47]. These observations are distinct from the
result of GGN6, in that the decreased helical propensity of the reduced
Rnx and brevinin-1E in water did not have a critical effect on their
activity, as described above. Nevertheless, another approach to the
reduced brevinin-1E is in support of the result from reduced GGN6.
The N-terminal two- or ﬁve-residue truncation of the hemolytic
peptide brevinin-1E results in a moderately impaired antimicrobial
activity with a remarkably decreased hemolytic activity [46]. The
reduction of the disulﬁde bond in this fragment still has no signiﬁcant
effect on the antimicrobial activity and helical adoption in SDS
micelles. However, at 1.25 mM SDS where the reduced GGN6
precipitated, the CD spectrum of the reduced brevinin-1E fragment
appeared in a totally different pattern, indicative of a β-sheet structure
and/or aggregations. Finally, it has been revealed that the reduction of
the fragment further decreased hemolytic activity without signiﬁcant
effect on antimicrobial activity.
In summary, the comparisons between oxidized and reduced
forms of gaegurins and their related peptides showed that the
conserved disulﬁde bond can stabilize the helical propensity corre-
lated with activity but would be differently applied to each peptide.
2.1.2. Substitution of cysteines
The results with linear mutants lacking the disulﬁde bridge are
also contradictory to one another. The linear mutant of GGN5, where
the two cysteines were substituted with serines, showed a remark-
able decrease of activity and helical content [28]. This result is not
consistent with that observed on the reduced forms of GGN4 and
GGN5 but in agreement with the result of the reduced GGN6 amide
(refer to the Section 2.1.1.). In the high-resolution structure, the C-
terminus of the linear GGN5 mutant frayed to be ﬂexible and
disordered even in SDS micelles, inconsistent with the loop-like fold
shown in both the oxidized and reduced forms of native GGN5. In
contrast, the linear (cysteines to serines) mutant of GGN6 in TFE/
water showed a stable α-helix elongated up to the C-terminus,despite the C-terminal substitutions [49]. Accordingly, the activity of
the linear GGN6 was comparable to that of native GGN6 [48–50].
Similar behavior was observed from a linear analogue of brevinin-1E
possessing acetamidomethylated (thus unable to form a disulﬁde
bridge) cysteines. This analogue also showed the activity and the
helical propensity just marginally decreased from those of native one
[46,47]. Another example with a linear mutant of esculentin-C, an
active variant of esculentin-1, showed a similar result as GGN6, but
suggests an alternative role of the disulﬁde bond for exerting activity
[51]. The substitution of cysteines with serines in the esculentin-C
did not signiﬁcantly affect the antimicrobial activity, evaluated as
lethal concentration. However, the bacterial killing kinetics, mon-
itored by time-killing courses, was different: the effect of the linear
mutant was slower than that of the cyclic molecule. An interesting
approach to the Rana box has been also constructed on brevinin-1E,
by transposing the C-terminal Rana box to a central location [47]. The
native brevinin-1 has potent hemolytic activity as well as anti-
microbial activity, unlike gaegurins that possess little hemolytic
activity. However, the brevinin-1E analogue with the transposed
Rana box (namely BA) showed a favorable selectivity: i.e. the
antimicrobial activity was retained or slightly increased but the
hemolytic activity was 10-fold lowered. Then, the reduced form of
the analogue (namely BAL) showed no detectable hemolytic activity.
This result could be interpreted from the viewpoint of electrostatic
charge interaction with membrane surface. The N-terminal half of
brevinin-1E is mostly hydrophobic while the three lysines are
localized in the C-terminal region, in particular two lysines being
constrained in the Rana box. Thus the transposition of the Rana box
to central position would confer a favorable distribution of positive
charges, thus preferentially stimulating the interaction with nega-
tively charged membranes of bacteria. Then, the transposed Rana box
without disulﬁde bond would further favor effective interaction with
negatively charged bacterial membranes but not with zwitterionic
eukaryotic membranes. Indeed it was conﬁrmed by CD spectroscopy
that brevinin-1E and the analogues show a different and dynamic
conformational behavior in various lipid vesicles with different
surface charge [47].
2.1.3. Concluding remarks: structural and functional implications
Based on this review, the antimicrobial activities of gaegurins and
their related peptides correlated with their propensity to stably
adopt the helical structure favorable for membrane permeation. For
this, the Rana box seems to play a role of C-terminal capping to
stabilize the helical structure, thus complementing a stable activity.
1625H.-S. Won et al. / Biochimica et Biophysica Acta 1788 (2009) 1620–1629The speciﬁc role of the Rana box in GGN4 will be further discussed in
the following sections. The C-terminal disulﬁde bond can also
provide a resistance to proteases such as carboxypeptidase Y.
However, sometimes the disulﬁde bond appears unnecessary for
activity. Thus, it seems to depend on the primary structure of each
peptide how much the conserved disulﬁde bond is critical for the
activity. In some cases, the conserved cysteine residues are crucial for
activity, irrespective of disulﬁde bond formation. To clearly rationa-
lize the necessity or a common contribution of the conserved
disulﬁde bond, more systematic and comparative experiments would
be necessary for a group of related peptides including GGNs 1–3.
However, there might be no coherent role of the moiety, thereby just
indicating a molecular diversity and individual speciﬁcity obtained
during evolution.
2.2. Action mechanism of gaegurin 4 (esculentin-2EM)
GGN4, a 37-residue antimicrobial peptide, is the longest one of
gaegurins and most well characterized in structure and functional
mode. However, there are currently some conﬂicting arguments on
the structure–activity relationships of GGN4. A synthetic insight
would provide a clue to interpret its action mechanism.
2.2.1. Pore-forming activity of GGN4
The membrane-lytic activity of antimicrobial peptides is often
directly measured by a dye leakage experiment in model membrane
systems, which represents one of the recent technical improvements
to gain a deeper insight about the lytic action [53]. Although the
membrane-lytic activity of GGNs has not yet been characterized by
that experiment, GGN4 has been suggested to function via a pore-
forming process since the ionophoric properties were evidenced by
electrophysiological approaches [54–56]. In brief, GGN4 formed
voltage-dependent and cation-selective pores in planar lipid bilayers.
The pore-forming activity was dependent on the peptide concentra-
tion [54] and recently a helix-induced oligomeric (maximally 10-mer)
transition of GGN4 was observed in a 15% hexaﬂuoro-2-propanol
(HFIP)/water solution [55]. Details are as follows.
Originally, the voltage-gated ion channels induced by GGN4 were
inferred in planar lipid bilayers under voltage clamp, by checking the
membrane conductance increasing upon addition of GGN4 [54].
When the membrane potential was deﬁned as that of the peptide-
added compartment with respect to that of the other compartment
(i.e., the current ﬂow from the peptide-added compartment to the
other compartment is deﬁned as ‘outward current’), the gate-like
activity was voltage-dependent, thereby increasing at more negative
voltages but rarely at positive voltages. The activity was also rarely
observed at low (∼0.03 μg/ml) concentration of GGN4 applied. As
the peptide concentration increased, the bilayers were more
frequently broken with larger change of conductance. The pore-
forming activity in acidic lipid bilayers was similar to or slightly
higher than that in neutral bilayers [54,56]. Considering the
positively charged characteristic of GGN4, it was anomalous that
the ion channels formed by GGN4 were selective for cations such as K
+ and indeed contradictory to the anion selectivity of other known
basic peptides [54]. Even lager cations such as TEA+ and NMDG+, of
which geometrical mean diameters are 6.6 and 7.3 Å, respectively,
were also transportable through the channels, although their
permeability was lower than that of K+ [55]. To allow the NMDG+
to pass, the diameter of the GGN4-induced pores should exceed 7.3 Å
that requires at least pentameric barrel-stave assembling of GGN4
[55]. Alternatively, as discussed by Eun et al. [55], it is likely that
GGN4 forms various oligomers in real membranes, thereby providing
heterogeneous pores with different sizes. In this case, the toroidal
pore that has a variety of sizes and lifetimes [4,35,36] is more
suggestible for the GGN4-induced ion channel, rather than a barrel-
stave pore, which is expected to have a consistent channel size[4,35,36]. The heterogeneity of the GGN4-induced pores had been
reﬂected from the fact that GGN4 induced widely heterogeneous
conductance in the planar lipid bilayers [54].
The ionophoric activity of GGN4 was also evaluated in bacterial
cells and human erythrocytes, by measuring K+ efﬂux [56]. The K+
efﬂux in Gram-positive bacteria (M. luteus) showed higher potency
and efﬁcacy and more rapid kinetics than that in Gram-negative
bacteria (E. coli). In contrast, all those parameters indicated a poor
activity in human red blood cells. These results well correlate with the
selective toxicity of GGN4. GGN4 exhibits more potent antimicrobial
activity against Gram-positive than Gram-negative bacteria, but little
hemolytic activity [7,27].
2.2.2. Role of Rana box in pore formation
The ionophoric activity of GGN4 has been also examined for its
reduced form and C-terminally truncated analogues, to deduce the
role of the C-terminal Rana box (residues 31–37). The reduction of the
C-terminal disulﬁde bridge between Cys 31 and Cys 37 did not have
signiﬁcant effect on the pore-forming activity of GGN4 [56]. This is
consistent with the previous result that showed no signiﬁcant
alteration of structure and antimicrobial activity, upon reduction of
the disulﬁde bond [27]. In contrast, truncation of the Rana box
resulted in a remarkable decrease of ionophoric activity. The N-
terminal 30-residue fragment lacking the Rana box was quite less
potent in inducingmembrane conductance in planar lipid bilayers and
in inducing K+ efﬂux from both Gram-positive and Gram-negative
bacteria [56]. Quantitatively, the ionophoric activity of the Rana box-
truncated fragment was less than 1/10 of the intact GGN4 activity, or
even negligible. However, the properties of the ion channels were
qualitatively preserved; i.e. the channels were selective to cations and
more potent in Gram-positive bacteria. Unfortunately, the precise
antimicrobial activity of the 30-residue fragment has not been
evaluated but a substantial decrease of antimicrobial activity was
conﬁrmed from another fragment with N-terminal 28 residues of
GGN4 [45]. Then, further truncation from the C-terminus impaired
more severely the antimicrobial activity. The N-terminal 23- and 22-
residue fragments of GGN4 showed no signiﬁcant activity [32,45]. The
absence of ionophoric activity in planar lipid bilayers was also
conﬁrmed for the 23-residue fragment [54]. Taken all together, the
C-terminal disulﬁde bond of GGN4 is not a requirement for its activity
but the C-terminal parts including the Rana box region is crucial for
activity, probably by complementing the membrane afﬁnity rather
than by participating in the transmembrane pore structure.
2.2.3. Structural insight
GGN4 is mostly unstructured in aqueous solution, as simply
evidenced by its far-UV CD spectrum that is characterized by a single,
strong negative band near 200 nm [27]. Only a nascent turn near the
Rana box could be supported inwater by a detailed NMR study [29]. In
the presence of organic co-solvents (TFE or methanol) or detergent
(SDS or DPC) micelles, the peptide is folded into a stable α-helical
conformation [27,29,30], which would represent its functional
structure. However, precise examinations of the three dimensional
structure by NMR have shown conﬂicting results dependent on the
solvent. The structures determined earlier in 50% TFE/water mixture
[27] and in SDSmicelles [30] showed a helix–loop–helix conformation
with two α-helices extending from residues 2 to 10 and from residues
16 to 32, linked by a ﬂexible hinge spanning between the residues 11
and 15. The loop region (residues 11–15) assumed a helix-like
conformation but was ﬂexible, thereby allowing an independent
movement of both helices without contact, at an angle of approxi-
mately 60°–120° to each other [27,30]. In contrast, the recent structure
in 80% methanol/water mixture indicated a helix–kink–helix topol-
ogy with a long helix encompassing residues 2–23 and the other
consisting of residues 25–34, intervened by a helix break at Gly 24
[29]. The bending angle between helices connected by the ﬂexible
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exhibits a completely or highly amphipathic characteristic as can be
seen in Fig. 2. However, it is not clear which structure is relevant to the
real functional state in biological membranes, which is discussed in
next section.
The former structure of GGN4 in TFE/water and in SDS micelles
could be validly determined since the peptide was prepared as a
recombinant protein, which was readily applied to isotope labeling for
heteronuclear NMR as well as homonuclear NMR [27,30]. The
arrangement of helices was additionally supported by heteronuclear
NOE experiments in SDS micells [30]. The result suggested that the
interhelical loop region (residues 11–15) determined is slightly more
ﬂexible than the helices. Additional structure of the N-terminal 23-
residue fragment of GGN4 in 50% TFE/water also supported the
presence of the interhelical loop. In this structure, the N-terminal
helix was preserved with similar length (residues 2–11) but the other
parts were predominantly frayed, probably due to the break of the
peptide bond at position 23 [32]. Then, a tryptophanyl substitution at
position 16 of the fragment stabilized the helical structure up to
residue 18 in TFE/water and to 20 in SDS micelles. Since the position
16 in the intact GGN4 is at the border between the loop region
(residues 11–15) and the C-terminal helix (residues 16–32), it was
reasonable to infer that the tryptophan stabilized the potential helical
propensity of the previous loop region as well as the C-terminal helix
destabilized by truncation [32].
The latter structure of GGN4 in methanol/water was determined
with a synthetic peptide but it could be also unambiguously
determined by employing very careful and massive NMR experiments
[29]. Additionally, the arrangement of helices broken at Gly 24 could
be supported by sequence comparison of related peptides. Inspection
of amino acid sequences foundmany potential or observed helix break
occurring near a position matchable to Gly 24. The structure in
methanol/water was also useful to drawa very plausiblemodel for the
pore-forming mechanism of GGN4. The suggested model from this
structure depicts that the long N-terminal amphipathic helix inserts
perpendicularly into the membrane and assembles into an oligomeric
bundle that forms an ionophore. This seems probable since the helical
length with 22 residues is able to span the membrane and the
amphipathic properties are generally requisite for helical bundle to
form ion pore in membranes [57]. The ﬂexible kink at Gly 24, in this
model, allows the C-terminal helix to lie on the membrane surface.
This is also likely in that the C-terminal Rana-box contains two lysines
of which positive charges would favor electrostatic interaction with
the negatively charged surface of bacterial membrane. In addition, as
noted above (refer to the Section 2.2.2.), it has been revealed that the
Rana box in GGN4 is not involved in the pore structure spanning
membranes but effects on the potency; i.e. the Rana box-truncated
fragment of GGN4 formed the ionophore at higher concentration [56].
2.2.4. Model for membrane permeation suggested
Strictly speaking, GGN4 forms ion pores rather than channels,
which tend to be more selective. Presently it is not clear which one of
the two different conformation of GGN4 is relevant to the real
functional state in biological membranes. However, an alternative
possibility that both of the two structures would be involved in action
mechanism cannot be excluded. The model encompassing both the
two structures is suggestible as in Fig. 3. Generally it is accepted that
the primary binding of the pore-forming peptides to membrane
occurs on the membrane surface with inducing helical structure from
the random structure in aqueous solution. The amphipathic helix is
requisite to stabilize this initial binding, where the hydrophilic face
interact with the lipid head groups and hydrophobic face contacts to
the inner parts of lipids with acyl chains. Finally the ionophore is
suggested to be formed transiently by oligomerization of the peptides
in a concentration-dependent manner. Based on this general
mechanism of pore-forming peptides [34–41], the former helix–loop–helix structure of GGN4 would be responsible for its primary
binding while the latter helix–kink–helix structure is assignable to the
ion pore formation as a barrel-stave or a toroidal pore (Fig. 3). The
heteronuclear NOE results suggested that the micelle-bound helix–
loop–helix peptide had some mobility of the helices, which would be
related to a membrane permeation process. In contrast, the helix–
kink–helix conformation possesses very suitable properties for
ionophore structure as discussed above (refer to the Section 2.2.3.).
A basic premise of the model in Fig. 3 is an additional
conformational change from the helix–loop–helix structure to the
helix–kink–helix structure during oligomerization and/or sponta-
neous insertion into membrane. As noted herein, the interhelical loop
region of the helix–loop–helix was ﬂexible but adopted a helix-like
conformation [27,30] and showed a potential helicity that can be
readily stabilized [32]. In addition, heteronuclear NOE result of GGN4
in SDS micelles indicated that the residue Gly 24, as well as the loop
region, is rather ﬂexible. Thus, the helix–loop–helix conformation
observed in TFE/water and in SDS micelles possesses a high potential
to be readily converted into the helix–kink–helix structure observed
in methanol/water.
Despite the plausible reasoning, the suggested model might be
criticized by the recent observation of GGN4 oligomerization. The
analytical ultracentrifugation of GGN4, combined with CD and
ﬂuorescence spectroscopy, indicated solely monomeric state in
methanol/water. In contrast, in the presence of a ﬂuorinated alcohol
HFIP (hexaﬂuoro-2-propanol), higher order aggregates were detected
[55]. HFIP, like TFE, is a strong enhancer ofα-helix formation and it has
been additionally suggested to be able to formmicelle-like aggregates
with water. Thus, this result is in opposition to the suggested model in
Fig. 3, where the helix–kink–helix structure in methanol/water was
assigned to the oligomeric state and the helix–loop–helix structure,
solved in TFE/water and in SDS micelles, was represented as a
monomeric form. However, previously in TFE/water and in SDS
micelles [27,30], no detectable oligomerization of GGN4 had been
indicated by CD and NMR parameters such as the ellipticity ratio at
222 nm to 208 nm [55,58] and NMR line broadening. Thus the two
types of GGN4 structures reﬂect its dynamic conformational prefer-
ences whether it associates or not. The extent of GGN4 oligomeriza-
tion in real membranes has been suggested to be various from
pentamers to decamers [55]. From this point of view, the suggested
conformational change in Fig. 3 from helix–loop–helix to helix–kink–
helix would not be responsible for oligomerization but attributable to
the transient membrane insertion. It has not been revealed whether
the GGN4-induced ion pore is formed as a barrel-stave pore or a
toroidal hole. The model depicted in Fig. 3 is effective for both the
mechanisms. However, if the toroidal pore is practical, both the two
structures of GGN4 might be favorable for its formation and adopt no
particular orientation [1,4,35–37]. To clarify the correct mechanism,
complementary experiments would be necessary in lipid bilayers to
detect both the two helical conformations and to deﬁne their
orientation.
2.3. Structural implications of gaegurins 5 and 6 (brevinin-1EMa and
1EMb)
GGN5 and GGN6, the 23-residue peptides, are the shortest ones of
gaegurins and commonly belong to the brevinin-1-like family (Fig. 1).
They undergo conformational changes as GGN4 does, from a
disordered structure in aqueous solution to a helical structure in
membranous environments. However, GGN5 and GGN6 are different
from the longer peptide GGN4, in that they possess a single α-helix
while GGN4 consists of two α-helices. As expected from their
sequence similarity, the overall structures of GGN5 and GGN6 are
also similar to each other. However, the same modiﬁcations of the
Rana box had quite different effects between GGN5 and GGN6, as
summarized above (refer to the Section 2.1.). In addition, speciﬁc roles
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two peptides, although they commonly possess that moiety. A
detailed and comparative inspection of the structural requirements
is provided as follows.
2.3.1. Structural characteristics
High-resolution structures have been obtained for synthetic
peptides corresponding to the native GGN5 and a linear (cysteines to
serines)mutant of GGN6 [28,49,50]. Since the GGN6mutant (CSGGN6)
was as active as native GGN6, it could represent the critical features in
structure of native GGN6 [48–50]. The structures have been solved in
SDSmicelles for GGN5and its analogues [28] and inTFE/watermixture
for CSGGN6 and its analogue [49,50]. The overall structures of GGN5
and CSGGN6 are very similar with a single amphipathic helix
encompassing residues 3–20 and 4–24, respectively. The N-terminal
end position (position 3) of the helix is occupied by glycine in GGN5
and proline in GGN6, which amino acids in polypeptides are often
appear at the end of a helix to function as a helix breaker or a helix
capping. Generally in NMR structures, it is hard to deﬁnitely deﬁne the
boundary of a helix and thus it is also arbitrary whether the Gly 3 and
Pro 3 in the GGN5 and CSGGN6 should be included in the helix element
or not. Considering together the different conﬁguration at the C-
terminus of CSGGN6, it can be regarded that GGN5 and GGN6 assume a
nearly identical conformation.
The most unique feature of the GGN5 and GGN6 structure is a
stable kink of the helix at the conserved Pro 14 (Fig. 4). Normally,
proline is not favorable for helix formation because it cannot
participate in the sequential hydrogen bonding network occurring in
a helix, due to the absence of amide proton. However, the ﬂanking
residues of the Pro 14 was sequentially linked in a continuing helix
[28,48,49]. The resultant was not a helix breaking at Pro 14 but only
the helical kink, through which the helix is persistent. Thus, the
kinked helix of GGN5 and GGN6 should be discriminated from the
helix–kink–helix of GGN4 in methanol/water. Amphipathic peptides
often adopt a curved α-helix [28,48,49,59]. The helices in GGN5 and
CSGGN6 also seem to be intrinsically a little (about 10°) curved. Then,
the helix becomes more bent by the Pro 14 that adopted the trans
peptide bond. The bending angle by the proline kink has been
estimated as about 25° [28], which is similar to that noted in many
other proline-containing helices [60]. The kinked helix exhibits a
typical amphipathic characteristic, where hydrophilic residues occupy
the convex face and hydrophobic residues converge into the concave
side (Fig. 4). In additional to the amphipathic properties, a
convergence of hydrophobic amino acids at the N-terminus is also
characteristic (Figs. 1 and 4).
2.3.2. Membrane binding mode and structural requirements
The membrane-bound orientation of GGN5 has been investigated
by spin label experiments in SDS micelles [28]. Mn2+, 5-doxyl
stearate, and 12-doxyl stearate were employed as the paramagnetic
probes monitoring the peptide location on the surface, beneath the
surface, and in the core of the micelles, respectively. The hydrophilic
residues in the convex of the helix and particularly at the C-terminal
region were located on the surface of the micelles, while the
hydrophobic residues in the concave and in particular at the N-
terminus were predicted under the surface of the micelles. From the
results, Park et al. [28] have proposed a plausible model for the initial
membrane-binding mode of GGN5, as shown in Fig. 4. Basically this
orientation facilitates and stabilizes both the charge interaction of
cationic amino acids with the anionic membrane surface and the
hydrophobic interaction of hydrophobic amino acids with the inner
parts of membrane. Thus, as suggested generally, the inherent helicity
and its amphipathicity would be a primary factor inﬂuencing the
interaction of GGN5 and GGN6 with membranes. Then, another
characteristic feature of the binding mode in Fig. 4 is provided by the
proline kink. The helical kink favors a diagonal binding of the peptidesto membrane, thereby anchoring the N-terminal hydrophobic cluster
more deeply into the core of membrane and exposing the cationic
amino acids in the Rana box onto the surface (Fig. 4). Particularly in
GGN6, the hydrophilic residues and especially all lysines are localized
in the C-terminal Rana box (Fig. 1). Thus the helical kink of GGN6
would be more efﬁcient to separately arrange the hydrophobic N-
terminus and cationic C-terminus, at the amphipathic interface of the
lipid bilayers.
The functional implications of the Rana boxwere inspected above in
the Section 2.1. The functional importance of the N-terminal hydro-
phobic cluster is veriﬁed by the N-terminally truncated analogues.
Deletion of the 1–3 or 2–4 segment in GGN6 completely abolished its
antimicrobial and anticancer activities [10]. The N-terminal 2–14, 3–13,
3–15, 4–16, and 5–17 fragments of GGN5 rarely exhibited antimicrobial
activities, while the 1–13 fragment was highly potent [31]. In other
related peptides such as brevinin-1E and Rnx, the N-terminal trunca-
tions often resulted in a striking decrease of activity [44,46].
In order to assess the functional role of the proline kink, the alanine
derivatives (P14A) of GGN5 and CSGGN6 have been examined in
structure and activity [28,49]. Structural effect of the P14A substitu-
tion was similar between GGN5 and CSGGN6. Although the P14A
analogues still adopted a curved helix, the outstanding kink at
position 14 disappeared and the substituted alanine was involved in
the intra-helical hydrogen bonding network. Finally, the helical
propensity (or the extent of helicity) and stability (or rigidity) were
increased in the P14A analogues. Nonetheless, the effect of the
substitution on activity was quite different between the two peptides.
The P14A substitution in the CSGGN6 showed a substantial decrease of
antimicrobial activity with still little hemolytic activity [49]. Similar
observation has been obtained from the maculatin 1.1, a 21-residue
antimicrobial peptide from Australian tree frogs, where the alanine
substitution at Pro 15 led to loss of activity [61]. In contrast, the P14A
substitution in GGN5 had little effect on the antimicrobial activity but
greatly increased the hemolytic activity [28]. Thus, the helical kink in
GGN5 and GGN6 seems to be important for both the activity and
selectivity of the peptides, but the extent to which the kink affect
would be different depending on amino acid composition. In
particular, based on the following evidences, the proline kink appears
to drive electrostatic interaction between the peptides and mem-
branes, which would be important for its selectivity to bacterial cells.
First, the P14A CSGGN6, compared to CSGGN6, had a considerably
increased binding afﬁnity for a neutral lipid, while both peptides
showed comparable afﬁnities for negatively charged lipids [49].
Second, the P14A GGN5, unlike GGN5, showed high toxicity to
erythrocytes, where the charge interaction between the peptide and
lipid head groups would not be critical. Another interesting ﬁnding
has been reported for the N-terminal fragments of GGN5. The N-
terminal 13-residue fragment of GGN5 (GGN5N13) still exhibited a
high antimicrobial activity but with concomitant hemolytic activity
[31]. This result strongly suggested that the C-terminal segment from
the proline kink would be critical for suppressing hemolytic activity.
However, it cannot be said that the C-terminal segment is unnecessary
for antimicrobial activity of GGN5, since the C-terminal substitutions
from cysteines to serines signiﬁcantly impaired the antimicrobial
activity. Probably the GGN5N13 is expected to possess antimicrobial
activity by a different mechanism from that of the intact GGN5.
In summary, in additional to the intrinsic helicity and the Rana box,
three other properties of GGN5 and GGN6 are suggested for their
structural requirements to properly interact with membranes at least
for primary binding: the amphipathicity of the helix, the helical kinkby
Pro 14, and the N-terminal hydrophobic cluster. The proline kink in
membrane-spanning helices has been postulated to aid in the gating
mechanism of ion-channel proteins, such as transport proteins and
pore-forming antimicrobial peptides [49,62]. However, it has not yet
been conﬁrmed whether the peptides ﬁnally function via a pore-
forming or the carpet-like mechanism. Amphipathic properties are
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mentary investigations would be required to clarify the action
mechanismand functional implications of the structural requirements.
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